Trial intelligence / Profile preview

Gemcitabine and Cisplatin in Advanced Breast Cancer

NCT00002998Phase 2Completed

Sponsor
Cancer and Leukemia Group B
Start
Aug 1997
Primary completion
Apr 2005
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of gemcitabine, cisplatin in breast cancer, sponsored by Cancer and Leukemia Group B. Started Aug 1997; status: completed.

02

Drugs

gemcitabinecisplatin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00002998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call